These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37878674)

  • 1. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.
    Wichroski M; Benci J; Liu SQ; Chupak L; Fang J; Cao C; Wang C; Onorato J; Qiu H; Shan Y; Banas D; Powles R; Locke G; Witt A; Stromko C; Qi H; Zheng X; Martin S; Ding M; Gentles R; Meanwell N; Velaparthi U; Olson R; Wee S; Tenney D; Parker CG; Cravatt BF; Lawrence M; Borzilleri R; Lees E
    Sci Transl Med; 2023 Oct; 15(719):eadh1892. PubMed ID: 37878674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
    Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
    Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
    Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
    Takao S; Akiyama R; Sakane F
    J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DGKζ exerts greater control than DGKα over CD8
    Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
    Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
    Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
    Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
    Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
    Andrada E; Liébana R; Merida I
    EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.
    Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ
    Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
    Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
    Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diacylglycerol kinases in cancer.
    Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
    Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling.
    Baldanzi G; Pighini A; Bettio V; Rainero E; Traini S; Chianale F; Porporato PE; Filigheddu N; Mesturini R; Song S; Schweighoffer T; Patrussi L; Baldari CT; Zhong XP; van Blitterswijk WJ; Sinigaglia F; Nichols KE; Rubio I; Parolini O; Graziani A
    J Immunol; 2011 Dec; 187(11):5941-51. PubMed ID: 22048771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy for hepatocellular carcinoma with diacylglycerol kinase alpha inhibition and anti-programmed cell death-1 ligand blockade.
    Okada N; Sugiyama K; Shichi S; Shirai Y; Goto K; Sakane F; Kitamura H; Taketomi A
    Cancer Immunol Immunother; 2022 Apr; 71(4):889-903. PubMed ID: 34482409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
    Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
    J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse.
    Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I
    Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
    Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.
    Velnati S; Centonze S; Girivetto F; Baldanzi G
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.
    Kureshi R; Bello E; Kureshi CTS; Walsh MJ; Lippert V; Hoffman MT; Dougan M; Longmire T; Wichroski M; Dougan SK
    Sci Adv; 2023 Nov; 9(47):eadk1853. PubMed ID: 38000024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ritanserin analogs that display DGK isoform specificity.
    Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
    Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.
    Torres-Ayuso P; Daza-Martín M; Martín-Pérez J; Ávila-Flores A; Mérida I
    Oncotarget; 2014 Oct; 5(20):9710-26. PubMed ID: 25339152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.